Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastine. 1984

J A Young, and S B Howell, and M R Green

Ten patients with advanced cancer were treated in a phase-I trial with monthly cycles of a 5-day infusion of vinblastine. Serum drug levels were relatively constant after 24 h and there was no correlation between drug level and myelosuppression or toxicity. Previously undescribed toxicities were observed, including one hypersensitivity reaction and three cases of severe, only slowly reversible, sensorimotor neuropathy. Two patients showed objective tumor regression during the vinblastine infusion therapy.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014747 Vinblastine Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.) Vincaleukoblastine,Cellblastin,Lemblastine,Velban,Velbe,Vinblastin Hexal,Vinblastina Lilly,Vinblastine Sulfate,Vinblastinsulfat-Gry,Sulfate, Vinblastine

Related Publications

J A Young, and S B Howell, and M R Green
June 1984, Cancer treatment reports,
J A Young, and S B Howell, and M R Green
March 1983, Cancer research,
J A Young, and S B Howell, and M R Green
January 1984, Anticancer research,
J A Young, and S B Howell, and M R Green
November 1987, Cancer treatment reports,
J A Young, and S B Howell, and M R Green
May 1984, Cancer treatment reports,
J A Young, and S B Howell, and M R Green
April 1988, International journal of cancer,
J A Young, and S B Howell, and M R Green
January 1991, European journal of clinical pharmacology,
J A Young, and S B Howell, and M R Green
June 1992, Journal of the National Cancer Institute,
J A Young, and S B Howell, and M R Green
January 1980, Cancer treatment reports,
J A Young, and S B Howell, and M R Green
July 1985, Cancer,
Copied contents to your clipboard!